Novo Nordisk Foundation

Global Science Summit Programme 2026

Up to DKK 7 million per grant| Deadline: 1 September 2026 (23 days)|Up to 3 years

14:00 Copenhagen time

Last verified: 9 August 2026

Deadline in 23 days. Check your match score for this grant before it closes. 30s, no email. See my matches →

The Global Science Summit Programme 2026 funds collaborative research on early detection and sustained adherence to cardiometabolic disease care, supported by AI and digital tools, with grants up to DKK 7 million over one to three years. This Novo Nordisk Foundation call requires a consortium of 2-3 interdisciplinary research groups led by a main applicant, open to researchers in Denmark. Projects addressing digital innovation or real-world patient engagement in cardiometabolic management are particularly competitive.

Details

Funder	Novo Nordisk Foundation
Budget	Up to DKK 7 million per grant
Deadline	1 September 2026
Duration	Up to 3 years
Consortium	Required — 2-3 research groups (main applicant plus 1-2 co-applicants from different disciplines and potentially different nations)
Application	Single stage
Frequency	One-off
Eligible countries	DK

Eligibility & scope

Funds interdisciplinary, collaborative science-based solutions using digital technologies and health data to address cardiometabolic diseases (CMDs), including multi-morbid conditions intersecting with reproductive health and infectious diseases. International location; open competition.

Who Should Apply

•Research groups with expertise in cardiometabolic disease, early detection, or patient adherence
•Researchers based at Danish institutions (main applicant and co-applicant groups)
•Teams with interdisciplinary strength spanning basic science, clinical practice, and digital/AI methodology
•Established investigators capable of coordinating a 2-3-group consortium and submitting via NORMA

Key Dates

•Deadline 1 September 2026, 14:00 Copenhagen time; call opens 1 July 2026
•Single-stage application; results announced December 2026
•Project duration 1-3 years

Tips for Applicants

✓Consortium structure is mandatory and scored: clarify the distinct contribution of each of the 2-3 groups upfront, and ensure co-applicant letters detail their specific role in early detection or adherence innovation.
✓Novo Nordisk's cardiometabolic focus favours proposals with a clear real-world implementation angle, pure algorithmic work or lab-only validation will score lower than projects with patient-facing or clinician-integrated digital tools.
✓Use the NORMA system submission window early (call opens 1 July); technical issues close to deadline are common and cannot be remedied after 1 September 14:00 CET.

Frequently Asked Questions

How much can I get from the Global Science Summit Programme 2026?

Individual grants are capped at DKK 7 million (approximately USD 1 million) for projects lasting 1-3 years.

Do I need co-applicants to apply for this Novo Nordisk grant?

Yes, the programme requires a consortium of 2-3 interdisciplinary research groups, with you as the main applicant and 1-2 co-applicants.

Who is eligible to apply for the Global Science Summit Programme 2026?

Researchers and research groups based at Danish institutions; international collaborators may join as co-applicants.

What is the application deadline and how do I submit?

Deadline is 1 September 2026 at 14:00 Copenhagen time; submissions must be in English via the NORMA system.

When will I hear the outcome?

Results will be announced in December 2026.

cardiometabolic-diseaseearly-detectionpatient-adherenceai-digital-toolsnovo-nordiskconsortium-requireddenmarktranslational

View full call →

Share ✉ Email X LinkedIn WhatsApp

Summary generated by AI based on published grant information. Always verify details on the funder's website.

More from Novo Nordisk Foundation

Browse all open grants →

Could Global Science Summit Programme 2026 be right for you?

Deadline in 23 days. See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.

See my matches free →